What the research found

Researchers analyzed data from 51 longitudinal studies to determine how different longevity interventions affect epigenetic aging clocks and other DNA methylation (DNAm) biomarkers. The study categorized interventions into four groups: lifestyle (diet and exercise), pharmacological agents (such as rapamycin and metformin), supplements, and medical procedures.

The analysis revealed that pharmacological interventions generally produced the most robust responses in DNAm biomarkers, likely due to their impact on metabolic and inflammatory pathways. Specifically, therapies targeting tumor necrosis factor (TNF) and certain variations of the Mediterranean diet showed consistent effects across multiple studies.

The team also found that not all "clocks" are equally sensitive. Second-generation biomarkers generally outperformed earlier versions. Notably, the DunedinPACE clock showed a high responsiveness to lifestyle changes and maintained consistent sensitivity regardless of whether the subjects were healthy or suffering from disease.

Why it matters for you

For those tracking biological age via epigenetic tests, this research suggests that the choice of "clock" significantly impacts the data you receive. If you are primarily focused on optimizing lifestyle factors—such as nutrition and training—the DunedinPACE metric may provide a more sensitive reflection of your progress than other biomarkers.

The findings also highlight the potential difference in "room for improvement" based on your baseline health. Those managing chronic inflammation or metabolic dysfunction may see more dramatic shifts in their epigenetic markers when starting a protocol than those who are already optimized.

Furthermore, the data suggests that pharmacological interventions targeting mTOR, AMPK, and TNF pathways may have a more pronounced effect on DNA methylation than supplements alone. This provides a theoretical framework for why certain medical-grade protocols might move the needle on biological age more aggressively than over-the-counter supplementation.

Caveats

  • This was a meta-analysis of existing studies rather than a single controlled trial.
  • Many findings rely on the responsiveness of biomarkers (proxies) rather than proven increases in actual lifespan.
  • Results vary significantly depending on which generation of epigenetic clock is used.
  • The observed effects of pharmacological interventions were linked to specific pathways (like TNF), which may not apply to all drugs in that category.